Dolby Laboratories Inc. (DLB) Tops Q3 EPS by 11c; Issues Very Strong FY11 Outlook; Announces $250M Buyback; Trading Halted
Get Alerts DLB Hot Sheet
Price: $62.37 --0%
Financial Fact:
Operating income: 29.09M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Operating income: 29.09M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Dolby Laboratories Inc. (NYSE: DLB) reported Q3 EPS of $0.65, $0.11 better than the analyst estimate of $0.54. Revenue for the quarter came in at $219 million versus the consensus estimate of $216.1 million.
Dolby Laboratories Inc. sees FY2011 EPS of $2.87-$2.96, versus the consensus of $2.60. Dolby Laboratories Inc. sees FY2011 revenue of $930-$955 million, versus the consensus of $932.18 million.
Announces a $250 million buyback plan.
Dolby Laboratories Inc. sees FY2011 EPS of $2.87-$2.96, versus the consensus of $2.60. Dolby Laboratories Inc. sees FY2011 revenue of $930-$955 million, versus the consensus of $932.18 million.
Announces a $250 million buyback plan.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Stock Buybacks, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share